GC Genome EV/FCF

Que fait GC Genome ? GC Genome Corp is a biotechnology company based in Yongin, South Korea, operating within the healthcare sector. The company specializes in clinical genome analysis, focusing on genetic testing services for various medical applications. GC Genome Corp provides prenatal and newborn screening, cancer patient precision diagnosis, and genetic testing for rare diseases. It also offers health checkup test services. The company has 125 full-time employees and completed its initial public offering (IPO) on June 11, 2025. Its headquarters are located in Yongin, Gyeonggi-Do. The company's website is https://www.gcgenome.com/. GC Genome Corp is engaged in the development and delivery of genetic testing solutions tailored to specific healthcare needs, emphasizing precision diagnostics in clinical settings. The firm's services are designed to support medical professionals in making informed decisions regarding patient care through advanced genomic analysis. The company operates in a specialized segment of the biotechnology industry, targeting both clinical and preventive healthcare markets. GC Genome Corp's business model centers on providing accurate and reliable genetic testing services to healthcare providers and patients seeking personalized medical insights. The company's IPO date marks its transition to a publicly traded entity, reflecting its growth and market positioning within the healthcare technology sector. GC Genome est l'une des entreprises les plus populaires sur Eulerpool.